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Abstract
The organization of intra-Golgi trafficking and the nature of the transport intermediates involved (e.g., vesicles, tubules, or
tubular continuities) remain incompletely understood. It was recently shown that successive cisternae in the Golgi stack are
interconnected by membrane tubules that form during the arrival of transport carriers from the endoplasmic reticulum.
Here, we examine the mechanisms of generation and the function of these tubules. In principle, tubule formation might
depend on several protein- and/or lipid-based mechanisms. Among the latter, we have studied the phospholipase A2
(PLA2)-mediated generation of wedge-shaped lysolipids, with the resulting local positive membrane curvature. We show
that the arrival of cargo at the Golgi complex induces the recruitment of Group IVA Ca
2+-dependent, cytosolic PLA2 (cPLA2a)
onto the Golgi complex itself, and that this cPLA2a is required for the formation of the traffic-dependent intercisternal
tubules and for intra-Golgi transport. In contrast, silencing of cPLA2a has no inhibitory effects on peri-Golgi vesicles. These
findings identify cPLA2a as the first component of the machinery that is responsible for the formation of intercisternal
tubular continuities and support a role for these continuities in transport through the Golgi complex.
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Introduction
After their synthesis in the endoplasmic reticulum (ER), cargo
proteins move to the Golgi complex. This unique structure
comprises numerous compact stacks of cisternae that are laterally
interconnected into the Golgi ‘‘ribbon’’ through tubular-reticular
networks (‘‘non-compact zones’’ [1]). Cargo proteins then traverse
the Golgi cisternal subcompartments (where they are glycosylated),
and at the trans-Golgi face they are sorted and delivered to their
further destinations via large tubular/pleiomorphic carriers [2–6].
Despite significant advances in recent years, important aspects
of the organization of intra-Golgi trafficking remain unclear.
Three main intra-Golgi transport models have been traditionally
considered for higher eukaryotes: trafficking by anterograde
vesicles [7], trafficking by compartment maturation-progression
[8–11], and trafficking by diffusion via tubular continuities joining
different Golgi cisternae [12–18]. Among these, the cisternal
progression model has recently gained broad consensus, although
the nature of the intermediates involved in this mechanism
(vesicles or intercisternal tubules) remains unclear. In addition,
more recently, a new model has been proposed by which cargo
molecules mix rapidly throughout the stack (compatible with cargo
diffusion via intercisternal continuities) and then partition into
specialized export domains before leaving the Golgi complex [19].
Thus far, intra-Golgi transport models, the last, diffusion via
tubular continuities, has received the least attention [12–17], and
even the very existence of intercisternal tubules has long remained
an issue of debate [20]. The main reasons for this uncertainty have
probably been the technical difficulties of detecting the convoluted
structures of the intercisternal tubules by traditional electron
microscopy (EM) and the traffic-related dynamics of these tubules
[18,21]. Over the last few years, however, tomography studies
have indicated that tubules can be shown to join successive Golgi
cisternae in animal cells, and that they form specifically under
conditions of active trafficking [17,18,21]. Thus, although
intercisternal tubules have still not been completely characterized
(for instance, quantitative data on their frequency remain scarce
[18,22]), they can be considered as potential players in intra-Golgi
trafficking. It is therefore of interest to understand and manipulate
their molecular mechanisms of formation.
PLoS Biology | www.plosbiology.org 1 September 2009 | Volume 7 | Issue 9 | e1000194The formation of an intercisternal tubule is likely to depend on
several molecular events, including mechanical deformation by
specialized proteins and changes in the distribution/geometry of
the lipids within the membrane bilayer [23,24]. These latter can
be induced in several ways, including the formation of local
spontaneous positive membrane curvature via the generation of
lysolipids and fatty acids by PLA2 activity [24,25]. Indeed, a role
for PLA2 in membrane shaping has been suggested in vitro [26], as
well as in a series of in vivo studies that have indicated that
chemical blockers of PLA2 suppress tubule formation in several
endomembrane compartments and inhibit the related trafficking
steps (see Brown et al. [27] for review).
Here, we show that transport through the Golgi complex
coincides with the rapid recruitment of a specific molecular PLA2
isoform onto Golgi membranes: Group IVA, Ca
2+-dependent
cytosolic PLA2 (cPLA2a). The activity of cPLA2a is required for
the formation of intercisternal connections in the Golgi. In
addition, we show that treatments that inhibit cPLA2a and
suppress intercisternal tubule formation also block intra-Golgi
trafficking of several cargo proteins. These data identify cPLA2a as
a component of the machinery underlying intercisternal tubular
continuities and support a role for these continuities in intra-Golgi
transport.
Results
As indicated above, PLA2 inhibitors have been reported to
suppress membranous tubules that extend from different cellular
compartments, including the Golgi complex [28,29]. We thus
sought to identify the Golgi-associated PLA2 isoform that might
serve as the molecular target of these inhibitors and might be
involved in the regulation of Golgi-associated tubular structures.
The superfamily of PLA2 enzymes consists of 15 groups
comprising secretory and cytosolic enzymes, with the latter
divided into Ca
2+-sensitive (cPLA2s, or Group IV PLA2s) and
Ca
2+-insensitive (Group VI, VII, and VIII PLA2s) isoforms [30].
Among those that are Ca
2+ sensitive, one of the Group IV
isoforms, cPLA2a, that is normally cytosolic has been reported to
associate preferentially with the Golgi complex upon moderate
increases in cytosolic Ca
2+ concentrations [31–34]. This affinity
for Golgi membranes prompted us to examine whether cPLA2a
might itself be involved in intercisternal tubule formation and
intra-Golgi trafficking.
Traffic Induces Binding of cPLA2a to the Golgi Complex
in a Ca
2+-Dependent Fashion
Initially, we asked whether cPLA2a is recruited to the Golgi
complex during activation of transport through this organelle. We
first generated a procollagen-I (PC-I) traffic pulse in human
fibroblasts (HFs) using the 40–32uC transport synchronization
protocol [8,35]. During the 40uC block, PC-I was diffusely
distributed in the ER and cPLA2a was mostly cytosolic (Figure 1A).
After releasing the block, PC-I reached the Golgi complex, where
its levels continued to increase for 30 min (Figure 1B). At the same
time, remarkably, cPLA2a was partially recruited to the Golgi
complex (Figure 1B). This cPLA2a increase on the Golgi complex
lasted for at least 30 min. Similar experiments were carried out
using the same 40–32uC transport synchronization protocol [35]
in other cell types (HeLa and MDCK cells) with the temperature
sensitive mutant of the vesicular somatitis virus glycoprotein
(VSVG) as cargo, a well-characterized trafficking marker [35,36].
VSVG can be expressed by either transfecting or infecting cells
with vesicular somatitis virus (VSV). In both cases, the generation
of a traffic pulse induced the recruitment of cPLA2a to the Golgi
complex (Figure 1F and 1G), as seen with PC-I. We further
examined the distribution of cPLA2a in the Golgi by immuno-EM.
We fixed VSV-infected cells expressing cPLA2a-GFP both during
the 40uC block and after releasing the block, and labelled the cells
with an anti-GFP antibody (ab). Most of the cPLA2a-GFP was
dispersed in the cytosol during the 40uC traffic block, with very
few gold particles on the ER and the Golgi complex. In contrast,
the cells fixed 30 min after releasing the block (i.e., during a traffic
wave) showed significant amounts of cPLA2a-GFP at the rims of
the Golgi cisternae and on rim-associated tubules (Figure 1H–1J).
Some cPLA2a-GFP labelling was still seen in the cytosol and at
low levels in the ER, but not on other intracellular membranes.
Notably, this distribution is consistent with an action of cPLA2a in
the formation of tubules from cisternal rims (see below).
To verify that this cPLA2a recruitment to the Golgi complex
was due solely to changes in membrane transport rather than to
the temperature changes required for inducing and releasing the
trafficking block, we infected HeLa cells with VSV (as above) and
then treated cells for 2 h with cycloheximide at 40uC (to deplete
the cells of cargo and thus reduce transport [18]). Under these
conditions, the temperature shift from 40uCt o3 2 uC did not
induce any significant changes in cPLA2a localization (unpub-
lished data).
We next investigated whether recruitment of cPLA2a to the
Golgi complex could be seen also under physiological steady-state
trafficking conditions, rather than only during traffic waves.
Indeed, HFs showed detectable levels of cPLA2a recruitment to
the Golgi complex also at steady-state (Figure 1C). Moreover,
when PC-I transport was inhibited using the 40uC temperature
block, cPLA2a lost its association with the Golgi complex, and
when trafficking resumed at 32uC, cPLA2a ‘‘rebounded’’ to high
levels on the Golgi complex (Figure 1A and 1B). Quantification of
cPLA2a levels on the Golgi under these conditions is shown in
Figure 1E. Recruitment of cPLA2a to the Golgi at steady-state was
detected also in other cell types (HeLa, MDCK, and HepG2). In
particular, in liver hepatoma HepG2 cells, which are professional
secretor cells that release up to 20 different soluble serum proteins
[37], the Golgi showed relatively high PLA2 levels (Figure 1D).
Thus, collectively, these data indicate that both ‘‘pulsed’’ and
steady-state trafficking through the Golgi complex induces the
association of cPLA2a with the Golgi membranes.
What is the mechanism of cPLA2a recruitment to the Golgi
complex? The binding of cPLA2a to membranes has been shown
to be due both to the Ca
2+-binding C2 domain and to the catalytic
domain of this protein. The C2 domain is required for initiating
membrane association, in a process that depends exclusively on
the intracellular Ca
2+ concentration ([Ca
2+]i) and has thus been
proposed to function as a calcium sensor [32], while the catalytic
domain prolongs this membrane binding of cPLA2a even after the
[Ca
2+]i has returned to lower levels [32]. We monitored the in vivo
dynamics of the calcium-sensor C2 domain of cPLA2a fused with
GFP (C2-GFP [32]) during the 40–32uC traffic pulse. Figure 1K
shows that C2-GFP had a diffuse cytosolic pattern when most of
the cargo protein (VSVG-YFP) was arrested in the ER. However,
as soon as VSVG started to concentrate within the Golgi complex
after the release of the traffic block (after 150–250 s), a significant
portion of C2-GFP moved from the cytosol to the Golgi complex
(Figure 1L and 1M; Video S1), and then gradually returned to the
cytosol. Under the same conditions, the full-length cPLA2a protein
shifted to the Golgi complex and remained there for over 30 min
(see above). This behaviour of C2-GFP and cPLA2a-GFP suggests
that the trafficking induces a transient increase in [Ca
2+]i, which in
turn initiates cPLA2a recruitment to the Golgi complex [32], an
interaction that would then be prolonged by the catalytic portion
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PLoS Biology | www.plosbiology.org 2 September 2009 | Volume 7 | Issue 9 | e1000194Figure 1. cPLA2a is recruited to Golgi membranes upon arrival of cargo from the ER. (A, B) HFs were incubated for 3 h at 40uC (A) and then
shifted to 32uC for 30 min in the presence of ascorbic acid (B), or HFs (C) and HepG2 cells (D) were grown under steady-state conditions. After fixing,
the cells were double labelled with antibodies against PC-I and cPLA2a and examined under the confocal microscope. (A) When PC-I was trapped in
the ER after the 40uC block, cPLA2a enrichment was not detected in the Golgi area. (B) Arrival of PC-I at the Golgi complex after release of the
temperature block induced cPLA2a binding to the Golgi complex. (C, D) Under steady-state conditions, the cells were fixed, labelled with antibodies
against cPLA2a and either PC-I (C) or giantin (D). Confocal microscopy reveals that here some cPLA2a can be seen in the Golgi area together with PC-I
(C) and giantin (D). (E) Fluorescence intensity of cPLA2a in the Golgi region (defined as giantin-positive area) was quantified and normalized to cPLA2a
intensity in the cytosol of HFs. Plot shows that Golgi/cytosol ratio of cPLA2a (mean6SD; n=20 cells) decreases in cells subjected to 40uC transport
block, but increases over the levels detected at steady-state conditions upon block release (at 32uC). (F, G) HeLa cells were infected with VSV and kept
at 40uC for 3 h to accumulate VSVG in the ER. The cells were then fixed (F) or shifted to 32uC for 30 min to allow VSVG to exit from the ER (G), and
prepared for confocal microscopy. Immunofluorescence labelling shows a diffuse pattern of cPLA2a when VSVG is blocked in the ER (F). In contrast,
cPLA2a undergoes recruitment to the Golgi membranes as soon as VSVG arrives at the Golgi complex from the ER (G). (H) HeLa cells were transfected
with cDNA encoding full length cPLA2a fused with GFP (cPLA2a-GFP), infected with VSVG, and subjected to the 40uC block. The cells were then fixed
30 min after the 40uC block release, to allow VSVG to reach the Golgi complex, and processed for immuno-gold EM with an anti-GFP ab, to reveal
cPLA2a-GFP localization. After activation of VSVG transport, a cPLA2a-GFP signal was detected at the rims of the Golgi cisternae and flanking tubular
structures (arrows). (I, J) Quantification of gold labelling (mean6SD; n=30 stacks) at the Golgi complex (see Materials and Methods) shows most of
the cPLA2a-GFP is bound to the tubular profiles (I) and the rims of the cisternae (J). (K, L) HeLa cells were co-transfected with the cDNAs encoding
VSVG-YFP and the C2 domain of cPLA2a fused with GFP (C2-GFP), kept at 40uC for 3 h (K), and observed in vivo under the confocal microscope during
VSVG-YFP release from the ER. Images extracted from the time-lapse sequence show that C2-GFP moves from the cytosol (K) to the Golgi membranes
(L) when VSVG appears within the Golgi area. (M) HeLa cells were transfected and incubated as above (K, L), and then observed under the confocal
microscope and fixed during VSVG release when detectable amounts of C2-GFP started to appear in the perinuclear area. Further staining with anti-
giantin antibodies reveals overlap of C2-GFP perinuclear signal with giantin labelling (arrows). Scale bar, 7 mm (A–D, F, G), 160 nm (H), 9 mm (K–M).
doi:10.1371/journal.pbio.1000194.g001
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clarified, it could be related to the high lumenal Ca
2+
concentrations in the Golgi complex [38] and the localization in
the Golgi area of the signalling machinery that is involved in the
release of Ca
2+ from intracellular stores [38,39]. Thus, the specific
recruitment of cPLA2a to the Golgi complex can be explained by a
local traffic-induced Ca
2+ release from the Golgi complex and
probably, additionally, by an intrinsic affinity of cPLA2a for the
Golgi (possibly due to its affinity for lipids and proteins that are
enriched in Golgi membranes [40–42]). Potentially related to this,
Ca
2+ released from the Golgi cisternae has been shown to be
required for intra-Golgi transport [43].
In summary, traffic moving through the Golgi complex triggers
the recruitment of cPLA2a to the rims of the Golgi cisternae,
possibly through a signalling mechanism [44] that might induce
the local Ca
2+ increase that is required for cPLA2a binding to
membranes [32].
Inhibiting cPLA2a Reduces Inter-Cisternal Tubules and
Suppresses Intra-Golgi Transport
We next examined whether cPLA2a is involved in the formation
of intercisternal tubules. Tubules can interconnect the stacked
Golgi cisternae in at least two ways: tubular non-compact zones
can join adjacent stacks ‘‘longitudinally,’’ to form the continuous
Golgi ribbon [1], and tubules can link the Golgi cisternae in the
cis-trans (‘‘vertical’’) direction within the same stack, as shown by
EM tomography and stereoscopy [12,18,21]. To examine the role
of cPLA2a here, we sought to inhibit/deplete cPLA2a by a variety
of approaches, while monitoring the presence/formation of Golgi
tubules. HeLa cells were first exposed to siRNAs directed against
cPLA2a. This resulted in a decrease in cPLA2a levels, as evaluated
by immunofluorescence (Figure 2A and 2B), western blotting
(Figure 2C), and cPLA2a activity assays under basal and elevated
Ca
2+ conditions (Figure 2D). In these cells, growth was partially
inhibited (50%–70%) in the last 24 h of exposure to the siRNAs;
however, cell viability did not appear to be affected. In these
cPLA2a-silenced cells, the Golgi ribbon was disassembled into
numerous fragments that remained perinuclear (Figure 2E,
asterisks, 2F), as has been previously described upon application
of PLA2 inhibitors [28,29]. EM showed that this was due to a
suppression of the longitudinal tubular elements (Figure 2G–2I) of
the non-compact zones [1], which resulted in the breakdown of
the Golgi ribbon into separate stacks (Figure 2H). We then
investigated whether this cPLA2a deficit also affects vertical
intercisternal connections, which are presumably more relevant to
cis-trans transport, using EM tomography (which is required to fully
reconstruct these tubular structures [18,21]). This showed that
tubules connecting different cisternae were present within
individual Golgi stacks in these cells (Figure 3A and 3B, arrows;
Video S2; see also below), as has been previously reported for
other cell types [18], and that these tubules were almost
completely suppressed by RNA interference (RNAi) of cPLA2a
(Figure 3C and 3D; Video S3). Other tools that specifically inhibit
cPLA2a had similar effects: both microinjection of an ab against
the catalytic domain of cPLA2a (see below) and treatment with the
selective inhibitors of cPLA2a catalytic activity pyrrophenone and
pyrrolidine (not shown) [45,46] induced a significant fragmenta-
tion of the Golgi ribbon corresponding to a reduction in the
tubular structures at the EM level (not shown). Of note, the tubules
in the non-compact zones and the vertical intercisternal
continuities always responded in the same way to a cPLA2a
deficit, suggesting that they both depend on the activity of cPLA2a.
Instead, other intracellular tubular structures (such as those of
endosomal origin, for example) were not affected by cPLA2a
depletion (not shown).
We also examined the effects of enhancing the levels of cPLA2a
by its overexpression. Remarkably, this treatment caused an
overall increase in the Golgi tubular elements that was sometimes
accompanied by a partial loss of the stack structure (Figure 2J),
further supporting the concept that PLA2a promotes Golgi
tubulation.
A further point was whether the tubulating effects of cPLA2a
arise from the formation of lysolipids, which can create positive
membrane curvature directly [24,27], or whether they are
mediated by the formation of arachidonic-acid (AA) metabolites,
perhaps via their signalling function. To test the latter possibility,
we used chemical inhibitors to block the main metabolic enzymes
of AA [47], the cyclooxygenases (using 50 mm indomethacin and
5 mm ibuprofen for 30 min) and the lipoxygenases (using 10 mm
ketokenazol for 30 min). These agents had no influence on Golgi
tubule formation (unpublished data), consistent with previously
reported observations [28]. Moreover, the addition of AA to
cPLA2a-siRNAs-treated cells did not counteract the ‘‘anti-
tubular’’ effects of the cPLA2a deficit. Altogether, these data
suggest that cPLA2a is required to support tubulation and that its
effects are mediated via the formation of lysolipids [24,25,27,28].
We thus turned to investigate whether disassembly of inter-
cisternal connections affects transport of cargo proteins across the
Golgi complex. To test this, we first suppressed intercisternal
connections by silencing cPLA2a, and then monitored the effects
of this treatment on intra-Golgi transport using the VSVG-
synchronized transport assay. We thus infected cPLA2a-depleted
cells with VSV and accumulated VSVG in the ER at 40uC, and
then we released the traffic block at 32uC. VSVG reached the
Golgi complex apparently normally, but then it accumulated at
the cis-Golgi pole (also inducing a moderate swelling of the cis
cisternae) and did not proceed through the Golgi complex
(Figure 4A–4E). Compatible results were obtained using biochem-
ical transport assays (see Materials and Methods) (Figure 4F and
4G). Rescuing the cPLA2a activity in cPLA2a-siRNAs-treated cells
by microinjection of recombinant cPLA2a resulted in the
reactivation of VSVG trafficking (Figure 4H). Further along this
line, an arrest of VSVG in the Golgi complex was seen also when
the cells were transfected with a dominant-negative cPLA2a
mutant [48] (Figure 4I), and when cPLA2a was acutely inhibited
by the microinjection of antibodies against the catalytic portion of
cPLA2a (Figure 5) or by specific inhibitors (not shown). Notably,
these inhibitory effects were marked but not complete (up to 60%–
80%; see Figure 4), possibly explaining the lack of visible toxicity
(at least within our experimental time frame).
A possible concern here is that these experiments were carried
out using a synchronization protocol that involves the sudden
arrival of a large cargo load at the Golgi complex, raising the
possibility that cPLA2a-dependent connections might have a role
only under conditions of Golgi overload. We therefore examined
whether the inhibition of cPLA2a would cause similar effects
during more ‘‘physiological’’ non-synchronized trafficking. To this
end, we infected cPLA2a-silenced cells with VSV and kept them at
32uC, to allow VSVG to continuously exit the ER. As was seen
during the 40–32uC synchronized pulse, VSVG reached the Golgi
complex but did not traverse it (see below), indicating that the role
of cPLA2a in intra-Golgi trafficking is not limited to conditions of
cargo overload.
The transport of other cargo proteins was also examined using
cPLA2a silencing. Ablation of cPLA2a in HFs resulted in a strong
delay of PC-I transport at the level of the Golgi complex
(unpublished data). The use of cyclooxygenase and lipooxygenase
cPLA2a-Dependent Tubules Drive Intra-Golgi Traffic
PLoS Biology | www.plosbiology.org 4 September 2009 | Volume 7 | Issue 9 | e1000194Figure 2. RNAi of cPLA2a affects Golgi-associated tubular structures. (A, B) HeLa cells were fixed 72 h after transfection of control scrambled
(A) and cPLA2a-specific (B) siRNAs and stained for cPLA2a and giantin. Confocal microscopy shows a strong reduction in cPLA2a labelling in cells
treated with the specific siRNAs (B). (C) HeLa cells treated with siRNAs as in (A) and (B) and prepared for western blotting with antibodies against
cPLA2a and actin. Expression of cPLA2a was strongly inhibited, while actin levels remained unaffected. (D) Quantification of cPLA2 activity (mean6SD;
measured using [
3H]-AA release; see Materials and Methods) revealed its reduction in cPLA2a-siRNAs-treated HeLa cells. (E, F) Control and cPLA2-
specific siRNAs-transfected HeLa cells. Labelling with an anti-giantin ab (E) and morphometric analysis (F) show extensive fragmentation of the Golgi
complex in cells with low cPLA2a expression (E, asterisks). (G–I) Control (G, I) and cPLA2a-siRNAs-treated HeLa cells (H, I) were fixed and prepared for
EM analysis. Tubular structures were seen to connect the Golgi stacks to each other (G, arrows) in control cells but were lost upon cPLA2a knock-
down (H). Morphometric analysis indicates a reduction in surface area (mean6SD; n=30 stacks) associated with tubular structures in the Golgi
complex in cPLA2a-siRNAs-treated cells (I). (J) HeLa cells transfected with cPLA2a-GFP, fixed and processed for immono-gold EM with an anti-GFP ab.
Cells overexpressing cPLA2a-GFP show numerous long tubular profiles in the Golgi region (arrows) and partial loss of stack organization. Scale bar,
45 mm (A, B), 22 mm (E), 300 nm (G, H, J).
doi:10.1371/journal.pbio.1000194.g002
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reverse the transport block in cPLA2a-siRNAs-treated cells, again
in parallel with the above effects on Golgi tubules. Thus, the
induction of a cPLA2a deficit and the attendant disassembly of
intercisternal connections appear to be associated with the
inhibition of intra-Golgi trafficking of different classes of cargo
proteins.
A further question is which type of connection is required for
trafficking. Our data indicate that the inhibition of cPLA2a
disrupts the ‘‘vertical’’ (cis-trans) and ‘‘longitudinal’’ (inter-stack)
tubular connections equally (see Figures 2 and 3). Thus, although
it may appear logical to assume that the vertical connections are
those relevant for transport, a role for the longitudinal connections
cannot be formally excluded by the above data. To resolve this
issue, we used a Golgi system that contains vertical, but lacks
horizontal, connections, and tested whether transport through
such a system is sensitive to the ablation of cPLA2a. A Golgi
complex with only vertical connections can be generated by
nocodazol (NZ) treatment, which results in the fragmentation of
the Golgi ribbon into isolated (non-horizontally connected) stacks
[18]. Any transport-relevant role of longitudinal connections can
be excluded in this system. Control and cPLA2a-deficient cells
were subjected to 3 h of 30 mM NZ treatment and processed for
EM tomography. As expected, vertical connections were revealed
in stacks of control cells (Figure 6A; Video S4), while in silenced
cells, these connections were almost absent (Figure 6B; Video S5).
To test the efficiency of transport under these conditions, the cells
were infected with VSVG and exposed to NZ during the 40uC
block, and then shifted to 32uC to activate transport. Figure 6C
shows that in control cells, VSVG moved to the plasma membrane
first through GM130-positive and then through TGN46-positive
compartments of the Golgi stacks, as has been previously reported
[18]. In contrast, in cPLA2a-silenced cells, VSVG was retained in
the Golgi stacks, where it showed strong overlap with the cis-Golgi
Figure 3. RNAi of cPLA2a affects intercisternal connections within the Golgi stack. Control (A, B) and cPLA2a-silenced (C) HeLa cells were
prepared for EM tomography after chemical fixation. (A, B) The digital slice (A) andzoom image (B; corresponding to the area outlinedby black box in A)
extracted from the tomogram (see Video S2) shows an intercisternal connection (arrow) bridging cisternae located at the different levels of the stacki n
control cells.(C)Digital imageextracted from the tomogramreveals nobridges betweencisternaewithinthe same Golgistack (see VideoS3)as well as a
lack of connection between neighbouring stacks (indicated by arrowheads). (D) Quantification of vertical connections per stack in sections (mean6s.e.;
n=10 stacks) in EM tomograms (see Materials and Methods), in control and cPLA2a-siRNAs-treated HeLa cells. Scale bar, 150 nm (A, C), 50 nm (B).
doi:10.1371/journal.pbio.1000194.g003
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PLoS Biology | www.plosbiology.org 6 September 2009 | Volume 7 | Issue 9 | e1000194Figure 4. RNAi of cPLA2a inhibits intra-Golgi transport of VSVG. (A–E) Control (A, B, D) and cPLA2a-siRNAs-treated HeLa cells (A, C, E) were
infected with VSV and kept at 40uC for 3 h to accumulate VSVG within the ER. The cells were fixed directly at the end of the block (A) or after a 60-min
(A) or 45-min (B–E) temperature shift to 32uC. (A) The cells were labelled with an anti-VSVG ab, showing that after accumulation within the ER, VSVG
was efficiently exported to the plasma membrane in control cells and blocked in the Golgi complex in cPLA2a-siRNAs-treated cells. (B–E) The cells
were triple labelled with anti-VSVG, anti-cPLA2a, and anti-TGN46 antibodies (B, C) or prepared for immuno-EM using the nanogold protocol (D, E). In
control cells, VSVG showed good colocalization with TGN46 in the Golgi area (B, inset); this colocalization was poor in cPLA2a-siRNAs-treated cells (C,
inset). In control cells, EM showed little VSVG in the cis portion of the stack (7.8%), with most (61%) within trans-Golgi compartments (D, arrows), post-
Golgi carriers (D, filled arrowhead), and at the plasma membrane (D, empty arrowhead). In cPLA2a-siRNAs-treated cells, most of the VSVG (62%)
remained within the swollen cis portion of the stack (E, arrows). (F, G) Control and cPLA2a-siRNAs-treated HeLa cells infected with VSV were
metabolically labelled with [
35S]-methionine and chased at 32uC. At the indicated times, the cells were solubilized and digested with endoglycosidase
H (Endo-H), which cleaves sugar chains built on the proteins early in the secretory pathway (i.e., before their processing by the medial Golgi enzyme
mannosidase-II, which convert sugars into an Endo-H resistant form). The cell lysates were then separated by SDS-PAGE, and the gels scanned (F). The
percentages of the Endo-H-resistant form of VSVG with respect to the total amounts of VSVG were quantified (G) using a FUJIFILM imager. The data
indicate that VSVG processing to its Endo-H resistant form (which occurs in the medial Golgi) was reduced when cPLA2a was silenced. (H) cPLA2a-
siRNAs-treated cells were infected with VSV, microinjected with recombinant cPLA2a during the 40uC block, and fixed 45 min after the block release
at 32uC. The cells were then stained with anti-VSVG and anti-cPLA2a antibodies and observed under the confocal microscope. VSVG was delivered to
the plasma membrane after cPLA2a microinjection (arrows) but remained in the Golgi in noninjected cells (asterisks). (I) HeLa cells were transfected
with VSVG-GFP and the dominant-negative cPLA2a(1–522) isoform, subjected to a 40uC block, and fixed 45 min after the temperature shift to 32uC.
Confocal images reveal VSVG-GFP blocked in the Golgi complex in cPLA2a(1–522)-expressing cells (asterisks). Scale bar, 60 mm (A), 6 mm (B, C),
270 nm (D), 200 nm (E), 15 mm (H), 8.5 mm (I).
doi:10.1371/journal.pbio.1000194.g004
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(Figure 6D). Thus, the disruption of vertical intercisternal bridges
by cPLA2a silencing inhibited the progression of cargo across NZ-
induced isolated stacks, which are devoid of horizontal connec-
tions. This provides evidence that it is the intercisternal
connections of the vertical type that are required for intra-Golgi
transport (see Discussion).
The Catalytic Activity of cPLA2a Is Required to Support
Intra-Golgi Transport
Our experiments with specific cPLA2 chemical inhibitors (see
above) taken together with already published observations [27]
suggest that the changes in lipid geometry during Golgi tubulation
require PLA2 catalytic activity. Nevertheless, given that the C2
domain of cPLA2a inserts deep into the membrane bilayer [49]
and could therefore be classified among the membrane-bending
protein modules [50], we wanted to determine whether it is indeed
the catalytic activity of cPLA2a, rather than the insertion of this
enzyme into the Golgi membranes, that is responsible for the
generation of tubules and transport across the Golgi.
We first tested whether cPLA2a maintains its ability to bind to
the Golgi complex in the presence of chemical inhibitors that
suppress intra-Golgi transport. VSV-infected HeLa cells were
treated with pyrrolidine, and the localization of cPLA2a was
monitored during a VSVG traffic pulse. cPLA2a translocated to
the Golgi complex to the same extent in control and inhibitor-
treated cells, but only the latter showed VSVG retention at the
Golgi (Figure 7A and 7B). Second, we examined the effects of two
cPLA2a mutants, cPLA2a
(1–522) and cPLA2a
S228C, which lack
PLA2 catalytic activity and yet show normal binding to
membranes [48,51]. cPLA2a
(1–522) is a deletion mutant that lacks
an amino acid (Asp549) essential for enzyme activity [52]. Of note,
Figure 5. Microinjection of an anti-cPLA2a ab inhibits intra-Golgi transport. (A–F) HFs were infected with VSV and kept at 40uCf o r3ht o
accumulateVSVGintheER.Thecellsweremicroinjectedwithan anti-cPLA2aab(mixedwithFITCdextran)duringtheblock,thenshiftedtothepermissive
temperature (32uC) and fixed at different times. (A, B) Staining of non-permeabilized cells with an ab against the ectodomain of VSVG 60 min after the
40uC block release shows reduced VSVG at the cellsurface in microinjectedcells (asterisks).(C, D)Microinjection withananti-cPLA2a ab (asterisks) induces
fragmentation of the Golgi complex, prevents delivery of VSVG to the plasma membrane, and blocks VSVG within the early Golgi compartment without
showingoverlapwithTGN46 (compareinsets 1 and 2 inpanel D,which correspondtodashedboxes inthe control andinjectedcells). (E, F)Morphometric
quantification shows poor colocalization of TGN46 with VSVG (E; mean6SD; n=50 cells) and a reduction in the number of post-Golgi carriers (F;
mean6SD; n=50cells)inanti-cPLA 2a-ab-microinjected cells, compared to mock-injected cells. Scale bar, 30 mm( A ,B ) ,7 . 5mm (C, D).
doi:10.1371/journal.pbio.1000194.g005
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PLoS Biology | www.plosbiology.org 8 September 2009 | Volume 7 | Issue 9 | e1000194Figure 6. RNAi of cPLA2a affects intercisternal connections and transport within NZ-induced Golgi ministacks. (A, B) Control (A) and
cPLA2a-silenced (B) HeLa cells were treated with 30 mM NZ for 3 h, then fixed and prepared for EM tomography. The digital slices extracted from the
tomograms (see Videos S4 and S5) show an intercisternal connection (arrow) bridging cisternae located at the different levels of the stack in control
cells (A) and reveals no bridges between cisternae within the Golgi ministack in silenced cells (B). (C, D) Control (C) and cPLA2a-siRNAs-treated HeLa
cells (D) were infected with VSV and kept at 40uC for 3 h in the presence of NZ to disassemble Golgi into ministacks and accumulate VSVG within the
ER. The cells were fixed directly at the end of the block or at indicated times after the temperature shift to 32uC. The cells were double labelled with
an anti-VSVG and either GM130 (cis-Golgi marker) or TGN46 (trans-Golgi marker) and investigated under confocal microscopy. In control cells (C), after
release of 40uC block, VSVG moved from the ER to the Golgi ministacks where it first colocalized with GM130 and then with TGN46 (see insets) and
finally arrived to the cell surface (arrows). In contrast, cPLA2a-silenced cells show VSVG within the GM130-positive compartment of ministacks (see
insets) even 60 min after release from the ER, with little or no VSVG detected both in the TGN46-positive compartment and at the plasma membrane.
Scale bar, 150 nm (A, B), 6 mm (C, D).
doi:10.1371/journal.pbio.1000194.g006
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PLoS Biology | www.plosbiology.org 9 September 2009 | Volume 7 | Issue 9 | e1000194Figure 7. The catalytic activity of cPLA2a is required to support intra-Golgi transport. (A, B) HeLa cells were co-transfected with cPLA2a-
GFP and VSVG-Cherry and exposed to the 40uC block to accumulate VSVG-Cherry within the ER. Pyrrolidine (1 mM; Pyr) was added to the cells (B)
15 min before block release. Then cells were shifted to 32uC in the absence (A) or in the presence (B) of pyrrolidine for 45 min, fixed, and investigated
under confocal microscopy. In control cells, VSVG-Cherry was detected at the cell surface (A) and its delivery to the PM was inhibited in pyrrolidine-
treated cells (B) ,while cPLA2a-GFP recruitment to the Golgi membranes was not affected by inhibitor treatment (compare A and B). (C–G) Control (C)
and cPLA2a-silenced (D–G) mouse MC3T3 cells were transfected with VSVG-Cherry alone (C, D) or in combination with the following human cPLA2a
constructs: cPLA2a-GFP (E), cPLA2a
(1–522) (F), cPLA2a
S228C (G). The cells were subjected to 40uC block, then shifted to 32uC (to activate VSVG-Cherry
exit from the ER) for 45 min, fixed, and stained with an anti-cPLA2a ab. Confocal microscopy revealed efficient delivery of VSVG-Cherry to the PM in
control cells (C), while in silenced cells, most of the VSVG-Cherry remained within the fragmented Golgi complex (D). Transfection of wild-type
cPLA2a-GFP rescued VSVG-Cherry delivery to the cell surface in cPLA2a-silenced cells, while expression of the catalytically inactive mutants cPLA2a
(1–
522) (F) or cPLA2a
S228C (G) did not reactivate VSVG-Cherry transport. (H) PCCL3 cells were loaded with [
3H]-AA (see Materials and Methods). Part of the
loaded cells was infected with VSV. Then infected and noninfected (control) cells were exposed to the 40uC block, washed, and shifted to 32uC. Fresh
medium was added to the cells for 3 min time intervals and then collected. The [
3H]-AA released into the medium over each 3 min-long interval was
measured (see Materials and Methods). Quantification of the AA release (mean6SD; n=6 experiments) revealed increase of PLA2 activity (with the
peak at 15 min) in VSV infected cells as compared to control. (I–L) HeLa cells were loaded with bis-BODIPY FL C11-PC (see Materials and Methods) and
fixed directly (I) or 15 min after incubation with either 5 mM ionomycin (J) or 1 mM pyrrolidine (K). The fluorescent signal indicating PLA2 activity was
detected by confocal microscopy both in the perinuclear region and the periphery of control cells (I). This signal increased after ionomycin treatment
(J), but decreased after pyrrolidine addition (K), as also revealed by quantification (L) of the mean fluorescence per cell (mean6SD; n=20 cells). (M, O)
HeLa cells were infected with VSV, kept at 40uC for 3 h, and loaded with bis-BODIPY FL C11-PC at the end of 40uC block. The cells were then fixed
directly at the end of the 40uC incubation (M) or at different time intervals after temperature shift to 32uC (N, O). The cells were then stained with
antibodies against VSVG and GM130 (Golgi marker). Confocal microscopy revealed only moderate PLA2 activity overlapping with the Golgi when
VSVG resided within the ER (M) while activation of VSVG transport through the Golgi (15 min after release from the ER) induced an increase in the
BODIPY signal in the Golgi area (N). Quantification of the mean BODIPY fluorescence per cell (mean6SD; n=20 cells) indicates an increase in PLA2
activity in cells actively transporting VSVG, as compared to uninfected (control) cells (O). Scale bar, 8.5 mm (A–G), 16 mm (I–K), 7 mm (M, N).
doi:10.1371/journal.pbio.1000194.g007
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(1–522) can be produced endogenously by caspase-mediated
cleavage at Asp
522 during apoptosis [48], and it can act as a
dominant-negative mutant of cPLA2a [48]. The cPLA2a
S228C
mutant contains a single point mutation in the active site, again
resulting in a complete loss of cPLA2a enzymatic activity [51].
Each mutant was transfected into cPLA2a-silenced cells and
compared to wild-type cPLA2a for its ability to rescue the
transport block induced by cPLA2a ablation and to translocate to
the Golgi complex. For the transport experiments, mouse cells
were transfected with VSVG carrying a red fluorescent tag
(VSVG-Cherry) and subjected to the transport-synchronization
protocol. VSVG-Cherry was efficiently delivered to the surface in
control cells (Figure 7C) but not in cPLA2a-silenced cells, as
expected (Figure 7D). The cPLA2a-silenced cells were then
transfected with either the mutants or the wild-type cPLA2a.
While the latter efficiently rescued VSVG-Cherry transport to the
cell surface (Figure 7E), as expected, neither cPLA2a
(1–522) nor
cPLA2a
S228C modified the transport block (Figure 7F and 7G).
However, both cPLA2a mutants translocated to the Golgi complex
as efficiently as wild-type cPLA2a (Figure 7F and 7G). Therefore,
these collective results indicate that the catalytic activity of
cPLA2a, rather than the ability of this enzyme to translocate to
Golgi membranes, is required to support transport across the
Golgi complex.
Finally, we sought to directly monitor the increase in cPLA2a
activation that based on the above data should occur during cargo
trafficking through the Golgi complex. First, we used a classical
PLA2 activity assay based on the release of [
3H]-AA from AA-
prelabelled cells [53]. A potential problem here is that during
cargo trafficking, only a fraction of the total cellular cPLA2a is
bound to the Golgi complex (which represents, in turn, less than
5% of the cellular membranes). Thus, the increase in AA release
over basal values might be very small. To overcome these
problems, we used two approaches.
For the first, in addition to HeLa cells, we used a cell line that
has been previously characterized in our laboratory to be an
efficient AA releaser (PCCL3 cells) [46]. Both cell types were
loaded with [
3H]-AA, infected with VSV, and subjected to a 40–
32uC transport synchronization protocol. When they were shifted
from 40uC to the permissive temperature of 32uC, the VSVG
expressing PCCL3 cells showed a modest but statistically
significant increase in AA release over that seen in control cells
(Figure 7H). This increase coincided in time with VSVG transit
through the Golgi complex. HeLa cells showed a trend in the same
direction, which, however, was not statistically significant. To
overcome this difficulty with HeLa cells, we used here a second
approach based on the fluorogenic phosphatidylcholine analogue
(bis-BODIPY FL C11-PC) as a sensor of local changes in PLA2
activity [54]. The hydrolysis of this lipid by PLA2 enzymes results
in generation of fluorescent products by fluorescence dequenching
[54]. After loading the bis-BODIPY FL C11-PC, HeLa cells at
steady-state showed a diffuse (ER-like) fluorescent signal in the cell
periphery (indicating ongoing PLA2 activity), and a clearer signal
in the perinuclear (Golgi) area (as assessed by confocal microscopy,
Figure 7I). In control experiments, the application of the calcium
ionophore ionomycin, which strongly stimulates cPLA2a [31],
markedly increased this signal both at the cell periphery and in the
perinuclear region, while the cPLA2a inhibitor pyrrolidine
reduced overall BODIPY fluorescence (Figure 7J–7L), indicating
that the probe functions as expected under our conditions. Then,
the cells were exposed to the 40–32uC VSVG synchronized traffic
pulse. During the 40uC block (Figure 7M) the cells did not show
any significant concentrating of fluorescence signal in the Golgi
area (consistent with the lack of transport through the Golgi and of
cPLA2a recruitment). When the traffic block was released, the
fluorescence signal increased selectively in the Golgi area, to nearly
2-fold the control (Figure 7N and 7O).
Thus, taken together, the AA release and the microscopy data
suggest that the catalytic activity of cPLA2a increases during the
passage of cargo through the Golgi complex and that this activity
is required for transport across the Golgi stack.
Suppression of cPLA2a Activity Does Not Inhibit Golgi
Vesicle Formation
A series of control experiments was then carried out. In the first,
we asked whether the inhibition of cPLA2a activity might have an
effect on the Golgi COPI vesicles. We thus inhibited/depleted cells
of cPLA2a and examined the features of the Golgi vesicles as well
as on the dynamics of the COPI machinery in these cells. cPLA2a
silencing affects neither the number nor the morphology of Golgi
vesicles (Figure 2H and 2I). We also blocked vesicle fusion with
their target membranes and monitored the kinetics of vesicle
accumulation as an indicator of the rate of vesicle formation. This
was achieved via inhibition of aSNAP (one of the main membrane
fusion factors) by incubating permeabilized cells with an L294A
aSNAP mutant that blocks fusion [55,56]. L294A aSNAP induced
an accumulation of Golgi vesicles, as expected. This accumulation
was the same in the absence and presence of the cPLA2a inhibitor
(Figure S1A–S1E). Also, the machinery responsible for COPI
vesicle formation was not affected by the cPLA2a inhibitor, as
judged by the COPI and ARF1 dynamics of association with Golgi
membranes in live cells (Figure S1F–S1K). Finally, we looked at
the effects of cPLA2a silencing on a known COPI-vesicle-
dependent trafficking step: the recycling of the KDEL receptor
(KDELR) from the Golgi complex to the ER. For this, we used a
well-characterized assay based on a KDELR-VSVG chimera [57].
This assay indicated that the KDELR recycles from the Golgi
complex to the ER equally well in control and cPLA2a-siRNAs-
treated cells (see below, Figure S2A–S2D), again indicating that
the COPI machinery is not inhibited by a cPLA2a deficit.
Thus, treatments that block cPLA2a suppress the formation of
intercisternal tubules while having no apparent inhibitory effects
on Golgi-associated COPI vesicles (which presumably rely mostly
on coat proteins for their curvature; [23]).
Specificity of the Effects of cPLA2a Inhibition on Different
Trafficking Steps
We also examined the specificity of the effects of cPLA2a on
several transport steps. Since cPLA2a is recruited selectively to the
Golgi complex upon activation of transport and its inactivation
selectively suppresses Golgi tubule formation, its effects on
trafficking should be restricted to the Golgi complex. In contrast,
some relatively nonspecific inhibitors of many PLA2 isoforms used
previously, such as ONO [58], have been reported to block
transport at multiple segments of the exocytic and endocytic
transport pathways that rely on tubular transport intermediates
(reviewed in Brown et al. [27]). To address this apparent
discrepancy, we compared the effects of cPLA2a RNAi and of
pyrrophenone with those reported for ONO [28,29].
First, we examined the effects of silencing cPLA2a on several
transport steps. These included retrograde transport of the
KDELR from the Golgi complex to the ER (as above; Figure
S2A–S2D) plus endocytosis and recycling of transferrin to the
plasma membrane (Figure S2E and S2F), and endocytosis of
wheat-germ agglutinin lectin uptake and its transport to the trans-
Golgi network (TGN) (Figure S2G and S2H). None of these steps
was affected by cPLA2a silencing. We also examined the TGN-to-
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block (at this temperature, VSVG is arrested and accumulates
both in the TGN and in the medial-trans Golgi cisternae [4]).
When the 20uC block was released in inhibitor-treated cells, a
large fraction of VSVG reached the plasma membrane normally
(presumably from the TGN), while the remaining fraction
(presumably residing in the medial-trans cisternae) remained
trapped in the Golgi complex (not shown), consistent with an
effect of cPLA2a silencing on intra-Golgi trafficking (see above)
and with a lack of effect on TGN-to-plasma-membrane transport.
Also, transport from the ER to the Golgi was not affected by
cPLA2a silencing, as shown above (see Figure 4). Furthermore, the
labelling of different proteins that reside in the endocytic
compartments (Figure S2I–S2L) or at the ER/Golgi interface
(Figure S2M–S2P) showed no significant changes after this specific
cPLA2a silencing. Thus, these data confirm the selectivity of the
cPLA2a role in intra-Golgi trafficking.
We then compared the above effects with those of ONO, a
relatively nonspecific drug that inhibits several PLA2 isoforms [27].
ONO inhibited the transport of VSVG (Figure S3A–S3F, S3K,
and S3L) and PC-I (Figure S3G–S3J). Moreover, ONO induced
the structural changes expected of PLA2 inhibition; namely,
fragmentation of the Golgi ribbon (Figure S4A and S4B) and
suppression of Golgi-associated tubular elements (Figure S4C–
S4E), including intercisternal connections (as revealed by EM
tomography) (Figure S4F and S4G; Videos S6 and S7). These
effects were reversible, as ONO wash-out resulted in a rapid
reappearance of bridges connecting cisternae within the stack
(Figure S4H–S4K; Video S8), which coincided with reactivation of
transport through the Golgi complex (Figure S3M–S3O). These
effects mimic those due to cPLA2a inhibition; however, in addition
to these, ONO had effects that were not seen in cPLA2a-silenced
cells, including the suppression of tubular structures in transferrin-
containing early endosomes (not shown). Moreover, ONO has
been shown by others to suppress the recycling of transferrin from
the endosomes to the plasma-membrane [59], as well as
retrograde transport from the Golgi complex back to the ER
[60]. It is possible that as an inhibitor of many PLA2 isoforms,
ONO has generalized effects on different membrane tubules
because these depend on activities of different PLA2 enzymes [27],
while cPLA2a is Golgi specific (see Discussion).
Other PLA2 Enzymes Support Trafficking in Cells Derived
from cPLA2a Knock-Out (KO) Mice
An apparent difficulty in this study is that cPLA2a KO mice
show reduced fertility but, surprisingly, no other major phenotypes
[61,62]. We examined whether cells obtained from these mice
show transport abnormalities. To test this, immortalized lung
fibroblasts (IMLFs) from cPLA2a KO mice (IMLFs
2/2) or control
mice (IMLFs
+/+) were infected with VSV and subjected to the 40–
32uC transport synchronization protocol (Figure S5). No signifi-
cant differences in VSVG transport were detected between
IMLFs
+/+ and IMLFs
2/2 (Figure S5A, S5C, S5E, S5G), except
that while intra-Golgi transport in IMLFs from control mice
showed the expected inhibition in the presence of the specific
cPLA2a inhibitor pyrrophenone, the IMLFs from KO mice were
insensitive (Figure S5B, S5D, S5F, and S5H). This suggests that
the latter cells had developed an adaptive mechanism to
compensate for the loss of cPLA2a (and, incidentally, confirms
the specificity of pyrrophenone). We considered the possibility that
this mechanism might be based on other PLA2s. To verify this, we
used siRNAs to screen for the roles of all of the cytosolic PLA2
proteins from Groups IV, VI, VII, and VIII of the PLA2
superfamily [30] in VSVG transport in these cPLA2a KO cells
(Figure 8). The efficiency of siRNA delivery was checked with
fluorescent siGLO. Among these siRNAs, only those silencing the
Ca
2+-independent Group VIIIA (GVIIIA)-PLA2 inhibited VSVG
transport, resulting in accumulation of cargo within the Golgi
complex (Figure 8L and 8P). Strikingly, this PLA2 isoform has
been detected by others at the Golgi membranes and appears to be
important for maintenance of the tubular elements of the Golgi
complex (W. Brown, personal communication). We also charac-
terized the effects of the GVIIIA-PLA2 ablation in IMLFs
2/2 and
saw clear similarities with the effects of cPLA2a silencing in
‘‘normal’’ cells. The Golgi remained perinuclear, but the ribbon
underwent fragmentation (i.e., it exhibited numerous breaks;
Figure 8P), presumably due to the loss of the tubular elements
connecting cisternae. VSVG reached the Golgi complex normally,
but to a large extent remained trapped in the Golgi complex,
where it showed substantial overlap with the cis-Golgi marker
GM130 (Figure 8P) (i.e., it remained in the cis-Golgi) and showed a
marked delay of protein progression across the stack. It is thus
likely that GVIIIA-PLA2 is responsible for compensating for the
cPLA2a deficit in KO cells (or animals) and for supporting
transport through the Golgi complex in these cells.
We also asked whether and to what extend GVIIIA-PLA2 is
involved in the regulation of transport in other cell lines with
normal levels of cPLA2a by evaluating transport both in control
IMLFs
+/+ and in HeLa cells depleted in GVIIIA-PLA2. The
silencing of GVIIIA-PLA2 inhibited VSVG transport less
markedly than that of cPLA2a, and the double knock-down of
these enzymes was slightly more effective than that of cPLA2a
depletion alone (Figure 9), indicating that GVIIIA-PLA2 has a
subsidiary role in normal cells.
Notably, these experiments were carried out under conditions of
both synchronized (high load) and non-synchronized (low load)
trafficking with similar results. Also notably, the traffic inhibition
was marked (up to 80%), but not complete, even in double KD
cells. This could be due either to incomplete silencing or to some
further compensatory effects, or also to the presence of redundant
transport mechanisms. As a consequence, silenced cells can
survive, although their rate of growth was significantly decreased
(by 60%–80%) in the last 24 h with the siRNAs, probably
reflecting this inhibition of their secretory trafficking.
Altogether, these observations indicate that cPLA2a is the main
regulator of transport across the Golgi complex under different
conditions of cargo load. GVIIIA-PLA2 has a minor role in intra-
Golgi transport when cPLA2a is normally expressed, but appears
to be able to compensate for the lack of cPLA2a to support
trafficking in cPLA2a KO mice.
Discussion
It has become clear in recent years that cells have at their
disposal a vast repertoire of protein-based and lipid-based
mechanisms for the bending of their membranes. The former,
which have been more extensively characterized, include coat
proteins such as clathrin, COPI and COPII complexes, as well as
BAR proteins [23,24,50], while the lipids include substrates and
products of phospholipases, acyltransferases, phospholipid transfer
proteins, and flippases [24,50]. The main finding in this study is
that in the Golgi complex, a specific PLA2 isoform, namely Group
IV cPLA2a, is required for the formation of the intercisternal
tubules that appear to be involved in intra-Golgi trafficking.
The simplest explanation for the role of cPLA2a in Golgi
tubulation is that this enzyme can induce the rapid accumulation
of wedge-like lysolipids at the cisternal rims, resulting in a local
increase in spontaneous positive membrane curvature, and hence
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PLoS Biology | www.plosbiology.org 12 September 2009 | Volume 7 | Issue 9 | e1000194Figure 8. GVIIIA-PLA2 inhibits transport of VSVG in immortalized murine lung fibroblasts from cPLA2a-KO mice. (A–P) IMLFs from
cPLA2a KO mice (IMLFs
2/2) were incubated with siRNAs specific for the different cytosolic PLA2 enzymes, and control siRNAs, for 72 h (A–P; as
indicated). The cells were then infected with VSV, kept at 40uC for 3 h to accumulate VSVG in the ER, and incubated in fresh medium at 32uC for
60 min before fixing. The fixed cells were either stained with only an anti-VSVG ab (A–O) or double labelled for VSVG and GM130 (P). VSVG was
efficiently exported to the plasma membrane in cells incubated with either control (O) or most of the PLA2-isoform-specific siRNAs (A–K, M–O).
However, RNAi of GVIIIA-PLA2 induced accumulation of VSVG within the Golgi complex of IMLFs (L). Notably, VSVG always overlapped strongly with
GM130 (see inset in P) in cells incubated with GVIIIA-PLA2-specific siRNAs, suggesting that VSVG is trapped within the cis-Golgi compartment. (R)
IMLF
2/2 and control lung fibroblasts from mice expressing cPLA2a (IMLFs
+/+) were incubated with siRNAs specific for either cPLA2a or GVIIIA-PLA2
and control siRNAs for 72 h. The cells were then infected with VSV, subjected to the 40uC block with its further release for 60 min and fixed. VSVG was
detected at the surface of IMLFs
2/2 and IMLFs
+/+ using an ab against its ectodomain. Afterwards, the cells were permeabilized and incubated again
with an anti-VSVG ab to reveal the total pool of VSVG within the cell. Then fluorescense intensities of surface and total VSVG were evaluated,
expressed as a ratio, and normalized to the control. This quantification reveals that cPLA2a silencing significantly inhibits VSVG transport in IMLFs
+/+
(but not in IMLFs
2/2), while GVIIIA-PLA2 RNAi strongly affects VSVG transport in IMLFs
2/2 and only slightly in IMLFs
+/+. Scale bar, 18 mm (A–O),
7.2 mm (P).
doi:10.1371/journal.pbio.1000194.g008
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of an intercisternal tubular continuity presumably requires the
assembly of the fusion machinery at the tip of the budding tubule,
for its connecting with a neighbouring cisterna. This, in turn, is
likely to involve the formation of an ARF/COPI coat to recruit
these fusion proteins into this bud [18,63,64]. Therefore, a simple
model that fits our observations is that the cPLA2a-generated
lysolipids help to create and stabilize the curvature of the necks of
COPI buds. This might prevent the fission of such buds into
vesicles, allowing these buds to dock and fuse with the next
cisternae, creating an intercisternal continuity. It is also possible
that the cPLA2a-generated lysolipids favour the elongation of buds
into tubules, as suggested by the observation that overexpression of
cPLA2a induces tubulation of the stack structure (Figure 2J).
Notably, for these events to occur, diffusion of the lysolipids away
from their site of synthesis should be limited by a diffusion barrier
at the Golgi rims (perhaps similar to the molecular fences
described at the plasma membrane [65]). This fence-like role
could involve the COPI coat that resides at the rims of the
cisternae. Future studies will elucidate these further components of
the tubulation machinery. As noted, the inhibition of cPLA2a and
the attendant abrogation of the tubules are associated with the
arrest of transit through the Golgi complex, indicating that the
cPLA2a-dependent intra-Golgi tubules are involved in trafficking.
Interestingly, a similar association between intra-Golgi tubules and
traffic has been reported for the effects of dicumarol. This drug is
Figure 9. VSVG transport efficiency in HeLa cells after depletion of cPLA2a and/or GVIIIA-PLA2. HeLa cells were incubated with control
siRNAs or siRNAs specific for cPLA2a, GVIIIA-PLA2, or both for 72 h. (A) Cells exposed to these siRNAs were infected with VSV and kept for 6 h at 32uC
to allow continuous synthesis and transport of VSVG through the secretory pathway (‘‘steady-state’’ conditions). Then the cells were fixed and VSVG
at the cell surface was stained with an ab against its ectodomain. Afterwards, the cells were permeabilized and incubated again with an anti-VSVG ab
to reveal the total pool of VSVG within the cell. Scale bar, 10 mm. (B) Cells were treated as in A or subjected to the 40uC block and then shifted to the
permissive temperature of 32uC for 60 min (‘‘traffic wave’’ conditions), fixed, and labelled for surface and total VSVG as described above. Then the
fluorescence intensities of surface and total VSVG were evaluated, expressed as a ratio, and normalized to the control. This quantification reveals that
under both ‘‘steady-state’’ and ‘‘traffic-wave’’ conditions, cPLA2a silencing inhibits VSVG transport much more strongly than GVIIIA-PLA2 depletion
(see also images in panel A). RNAi of both PLA2 enzymes, in turn, shows a slightly stronger inhibitory effect on VSVG transport over cPLA2a silencing
alone. (C) Cells incubated with different siRNAs (as described above) were subjected to western blotting with antibodies against either cPLA2a or
GVIIIA-PLA2 or GAPDH, as indicated.
doi:10.1371/journal.pbio.1000194.g009
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suppresses horizontal Golgi tubules (and thus, presumably, also the
vertical intercisternal tubules, which, however, were not directly
examined) and inhibits intra-Golgi trafficking [66]. Thus,
suppressing the tubules appears to result in the arrest of trafficking
independently of the molecular mechanisms that underlie tubule
disruption.
How do cPLA2a-dependent tubules support intra-Golgi traffick-
ing, and which are the tubules—longitudinal or vertical—that are
involved in intra-Golgi transport? The simplest hypothesis is that
Golgi tubules allow the intercisternal diffusion of molecules crucial
for trafficking. Both vertical and longitudinal tubular elements are
cPLA2a-dependent. The former are much less abundant; however,
since traffic requires movement along the cis-trans (i.e., vertical) axis,
they mustbe functionally crucial (as alsosupportedby investigations
in NZ-treated cells). Moreover, while relatively infrequent and
difficulttodetect[18,21,22],verticaltubules have thepotentialtobe
a very efficient means of intra-Golgi transit due to the great speed of
diffusion over short distances (microns in the Golgi complex). Thus,
very few vertical tubules per stack can be sufficient to achieve rapid
diffusion between the cis and trans compartments of the Golgi
complex (see Figure S6). This may be the case even when the
connections are fewer than those required for complete intra-stack
connectivity. For instance, in the Golgi ribbon, where stacks are
connected to each other by horizontal membrane bridges, gaps in
onestack might be compensated for byconnections in neighbouring
stacks (in this sense, also horizontal tubules may contribute to cis-
trans diffusion; Figure S6). Connections might be transient; here,
again, very few connections need to be present in a stack at any
given time to support intra-Golgi diffusion if they rapidly open and
close between cisternae (Figure S6). Given the above, the question
arises as to the role of intercisternal diffusion in intra-Golgi
trafficking of cargo proteins that cross the Golgi by cisternal
maturation/progression, such as PC-I and VSVG [35]. The
simplest hypothesis is that these tubules allow retrograde movement
of Golgi membranes and resident proteins (e.g., enzymes), which is
required for maturation [18,21]. According to this scheme (also
discussed elsewhere [18]), during cisternal progression, the Golgi
enzymes diffuse through the intercisternal continuities and explore
the Golgi space, where they partition according to their physico-
chemical properties into those cisternae that have their most
favourable composition. This partitioning is driven by a physico-
chemical gradient that is maintained across the stack at all times,
possibly by the input of compositionally different intermediate
compartment membrane into the cis cisternae and of endosomal
membrane into the trans-Golgi. Thus, the arrival of intermediate
compartment membranes at the cis pole (accompanied by
consumption at the trans) promotes both enzyme backflow and
cisternal progression (above), resulting in the synchronization of
thesetwoeventsandthemaintenanceof Golgipolarity.Clearly, this
model requires more work to fully test it experimentally, but at this
stage, it provides a logical explanation of the observations. At the
same time, it should be noted that while our data point to a crucial
role for tubules, complementary transport mechanisms cannot be
excluded. For instance, if Golgi tubules indeed arise from the
stabilization of COPI vesicles, as proposed above, it is possible that
trafficking might switch between vesicular [67,68] and connection-
mediated modes, with one or the other mechanism prevailing,
depending on the cell type and the functional state.
How ‘‘general’’ is the requirement for cPLA2a-dependent tubules
in trafficking? Our findings show that the role of cPLA2a,i sv e r y
specific for intra-Golgi tubular structures and trafficking. However,
other (non-Golgi) tubulation-dependent transport steps have been
reported to be blocked by PLA2 inhibitors. For instance, ONO
(a rather nonspecific inhibitor of many PLA2 isoforms) has been
shown by us and others to also suppress non-Golgi tubules and to
block non-Golgi transport steps that appear to be dependent on
tubular intermediates, including endosome-to-plasma-membrane
recycling of transferrin [59] and retrograde transport from the Golgi
complex to the ER [60]. It is thus possible that these transport steps
[59,60] are regulated by other PLA2 isoforms that are located in the
different organelles. For instance, cPLA2b and cPLA2e have been
reported to be located to the early [69] and late [70] endocytic
compartments, respectively, and may be involved in the regulation of
Figure 10. Schematic illustration of cPLA2a action at the Golgi complex. Inset 1: cPLA2a hydrolyses the fatty acids (FA) at the sn-2 position of
cylindrical phospholipids to form wedge-shaped lysophospholipids. Inset 2: This formation of wedge-shaped lysophospholipids favours generationo f
spontaneous membrane curvature and transformation of flat cisternae-like membranes into highly curved tubular membranes, which serve as
intermediates for transport across the Golgi stack.
doi:10.1371/journal.pbio.1000194.g010
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and that require PLA2 activity [27,59]. If this is the case, then the
PLA2 family in general (through different PLA2 isoforms), rather than
cPLA2aitself,could underlie a membrane-bending mechanism based
on the induction of spontaneous membrane curvature [24] that is
involved in tubulation and trafficking at the different levels of cellular
membranes in mammals [27]. A further observation that is most
probably related to these considerations is that mice knocked out for
cPLA2a have reduced fertility, but do not show any other major
phenotypes [61,62], and that secretory transport and Golgi
morphology in IMLFs obtained from KO mice [71] are normal.
This appears to be because cPLA2a in KO cells is functionally
replaced by GVIIIA-PLA2 (Figure 8). GVIIIA-PLA2 also partially
localizes at the Golgi complex, where it appears to control tubulation
processes (W. Brown, personal communication). Whether the
mechanisms of action of this enzyme in trafficking are similar to
those of cPLA2a is unclear at this time. At the mechanistic level, the
properties of GVIIIA-PLA2 are not well defined in vivo. Although
GVIIIA-PLA2 has been shown to have specificity in vitro towards
PAF-like lipids, its endogenous substrates remain unknown [72].
Thus, the precise metabolic reactions by which GVIIIA-PLA2
supports tubulation remain to be determined.
In conclusion, the activity of cPLA2a appears to be an
important mechanism for the formation of Golgi tubules in
mammalian cells [24]. For other tubulation events (in other
organelles or cell types), as noted, this role of cPLA2a might be
taken on by other PLA2 isoforms or even other phospholipases
(yeast). Nevertheless, the identification of cPLA2a as a player in
Golgi tubulation is a key finding, in that it reveals that generation
of lysolipids is an important event in the formation of cellular
tubules, and it should open the way towards the unravelling of
further components of the tubulation machinery. It is now
important to elucidate the mode of action of the intercisternal
tubular connections and to define their underlying molecular
machinery as well as the relationships of these tubules with other
key players in intra-Golgi trafficking [73,74].
Materials and Methods
Antibodies and Reagents
Ab sources: Ab against TGN46 from S. Ponnambalam
(University of Dundee, Dundee, UK); Ab against PC-I from
L.W. Fisher (NIH, Bethesda, MD, USA); Ab against giantin from
H-P. Hauri (University of Basel, Basel, Switzerland); Ab against
GM130 and ecto-domain of VSVG from M.A. De Matteis
(Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy). Ab
against GFP and decorin from Abcam (Cambridge, UK); Abs
against actin and VSVG from Sigma-Aldrich (Milan, Italy); Abs
against cPLA2a from Santa Cruz Biotechnology (San Diego, CA,
USA) or were produced in our laboratory according to standard
protocols. The Alexa 488, 546, and 633 IgG conjugates were from
Molecular Probes Europe BV (Leiden, The Netherlands). The
NANOGOLD gold-Ab conjugates and the GOLDENHANCE-
EM kit were from Nanoprobes (Stony Brook, NY, USA). cDNA
sources: cPLA2a-GFP from C. Leslie (National Jewish Medical
and Research Center, Denver, CO, USA) and T. Hirabayashi and
T. Shimizu (University of Tokyo, Tokyo, Japan); cPLA2a
(1–522)
from I. Kudo (Showa University, Tokyo, Japan); C2-GFP from
R.L. Williams (MRC, Cambridge, UK); cPLA2a
S228C from B.P.
Kennedy (Department of Biochemistry and Molecular Biology,
Merck Frosst Center for Therapeutic Research, P.O. Box 1005,
Pointe Claire-DorVal, Canada); L294A aSNAP from R. Burgoyne
(University of Liverpool, Liverpool, UK); VSVG-YFP, VSVG-
Cherry, VSVG-KDELR, and ARF1-GFP from J. Lippincott-
Schwartz (NIH, Bethesda, MD, USA); sialyltransferase-HRP from
D.F. Cutler (University College London, London, UK). ONO-RS-
082 was from Alexis (Lausen, Switzerland), pyrrophenone was
from K. Seno (Shionogi Research Laboratories, Osaka, Japan),
pyrrolidine was from Calbiochem (San Diego, CA, USA), bis-
BODIPY FL C
11-PC was from Molecular Probes (Eugene, OR,
USA), [
3H]-AA was from Amersham Pharmacia (Piscataway, NJ,
USA).
Cell Culture, Transfection, RNAi, and Infection with
Vesicular Stomatitis Virus
HeLa, MDCK, MC3T3, NRK and PCCL3 cells, HFs, and
IMLFs from cPLA2a-KO mice were cultured in DMEM
(Invitrogen SRL, Milan, Italy) supplemented with 10% foetal calf
serum and 1 mM L-glutamine. LipofectAMINE 2000 and
Oliogofectamine (Invitrogen, Carlsbad, CA, USA) were used for
the cDNA and cPLA2a-directed siRNA (SMART Pool, Dharma-
con , Chicago, IL, USA) transfections, respectively. Of note, both
the mixture of siRNAs as well as two of the individual cPLA2a-
specific siRNAs from the SMART pool were effective in knocking
down cPLA2a. The sense oligonucleotide sequences for human
cPLA2a are:
(#1) GGACAGUCGUUAAGAAGUA,
(#2) GGAGAAACACUAAUUCAUA,
(#3) GGAGAAGACUUUCAGACAA,
(#4) GUACAAGGCUCCAGGUGUU.
The pool of three siRNA (QIAGEN Inc., Valencia, CA, USA)
was used to silence mouse cPLA2a. The sense oligonucleotide
sequences for mouse cPLA2a are:
(#1) CCAGATGAATTTGAACGAATA,
(#2) AAGCCTGAGGATTCTCATTTA,
(#3) TAGGAGAAACACTAATTCAAA.
The efficiency of cPLA2a knock-down was evaluated by either
western blotting or immunofluorescense. Infection of cells with
VSV was performed as described previously [18]. For VSVG
rescue experiments, HeLa cells were incubated with oligonucle-
otide #4 (directed against amino acids 649–655) and then
transfected with mouse full length cPLA2a or the human
cPLA2a
(1–522) mutant. Alternatively, mouse MC3T3 cells silenced
for cPLA2a with pool of three oligonucleotides were transfected
with full length human cPLA2a or human cPLA2a
(1–522) or
cPLA2a
S228C mutants.
Cell Microinjection
VSV-infected HFs were microinjected with 4 mg/ml anti-
cPLA2a ab in the presence of FITC or TRITC dextrans during
the course of the 40uC block, using an Eppendorf transjector 5246
(Eppendorf, Milan, Italy). They were then shifted to 32uC and
processed for confocal microscopy. Similarly, VSV-infected
cPLA2a-silenced HeLa cells were injected with 2 mg/ml recom-
binant cPLA2a protein in resque experiments.
Treatment with the aSNAP Mutant
HeLa cells were permeabilized with streptolysin-O and
incubated with the recombinant L294A aSNAP (4 mg/ml) protein
in the presence of cytosol and an ATP-regenerating system, as
described in Kweon et al. [56].
Immunofluorescence, Confocal Microscopy, and Live-Cell
Imaging
For immunofluorescence analyses, the cells were fixed with 4%
paraformaldehyde and permeabilised in0.02%saponin, 0.5% BSA,
and 50 mM ammonium chloride prior to their incubation with the
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mounted in mowiol and examined on a Zeiss LSM 510 META
confocal microscope (Carl Zeiss, Gottingen, Germany). All confocal
images were obtained using the necessary filter sets for GFP, Alexa
488, and Alexa 546 using a Zeiss Plan-Neofluor 636oil immersion
objective (NA 1.4), with the pinhole set to one Airey unit. Overlap
between different markers was quantified using the ‘‘Co-localiza-
tion’’ module of LSM 3.2 software (Zeiss). Time-lapse images were
obtained using a Zeiss LSM510 META confocal microscope. Cells
co-expressing GFP and YFP fusion proteins were observed at 32uC,
as in the case of VSVG-GFP in 20 mM HEPES buffered DMEM.
Temperature was controlled with a Nevtek air stream stage
incubator (Burnsville, VA, USA). GFP molecules were excited with
the 488 nm line of a krypton-argon laser and imaged using the l-
scan mode of the META detector. Confocal digital images were
collected using a Zeiss Plan-Neofluor 636oil immersion objective
(NA 1.4) and GFP and YFP fluorescence was unmixed using LSM
3.2 software. Selective photobleaching in the regions of interest
within the cell was carried out on the Zeiss LSM510 using 100
consecutive scans with a 488 nm laser line at full power. Average
fluorescence intensities within regions of interests were quantified
using the LSM 3.2 software.
Electron Microscopy
For routine EM and EM tomography, the cells were fixed with
1% glutaraldehyde. EM tomography and morphometry on thin
sections and tomograms were all performed as described
previously [18]. Vertical intercisternal connections were defined
as tubular elements, which link different cisternae within the same
stack (or cisternae located at different levels across neighbouring
stacks). They show a clearly visible lumen (with minimal diameter
of 10 nm at the narrowest point along their length) through at least
two subsequent tomogram slices. The number of connections for
each stack was calculated in each single tomogram of 200 nm
thick single sections and expressed as ‘‘connections per stack in
section.’’ For pre-embedding gold labelling, cells were fixed with
4% formaldehyde and 0.1% glutaraldehyde, washed, incubated
with the primary ab overnight, and then with Nanogold
conjugated Fab fragments of the secondary antibodies (Nanop-
robes) for 2 h. The Nanogold particles were developed using the
Gold-enhance kit. For visualization of the trans-Golgi, NRK cells
expressing ST-HRP were fixed as indicated above, washed, and
incubated with a mixture of DAB and H2O2, as previously
described [3]. Both HRP and gold-labelled cells were embedded in
Epon and sectioned. EM images were acquired from thin sections
under a Philips Tecnai-12 electron microscope (Philips, Einhoven,
The Netherlands) using an ULTRA VIEW CCD digital camera
(Soft Imaging Systems GmbH, Munster, Germany). Quantifica-
tion of gold particles was carried out using the AnalySIS software
(Soft Imaging Systems GmbH, Munster, Germany).
Endo-H Resistance Assay
To determine Endo-H resistance, cells were initially infected
with VSV for 1 h and 32uC. The excess virus was then washed off,
and the cells were incubated in DMEM containing 10% HEPES
for 2 h at 32uC. The cells were then washed three times with PBS
and starved in DMEM without methionine and cysteine for
30 min at 32uC. The cells were then pulsed for 5 min with
200 Ci/ml [
35S]-methionine in DMEM without methionine and
cysteine. To stop the pulse, 10 ml 0.25 m methionine in complete
DMEM was added, and the cells incubated for 2 min at 32uC. A
subset of the samples was then transferred to ice and this was
considered Time 0. Other samples were washed with complete
medium and chased for the indicated times at 32uC. At the end of
the chase, the cells were washed once in PBS and lysed in 1 ml
lysis buffer (70 mM Tris [pH 7.4], 150 mM NaCl, 0.5% SDS, 1%
Triton X-100, 1 mM EDTA, and 1 mM PMSF) and incubated
for 60–90 min on ice. The lysates were centrifuged, and the
supernatants were incubated with an anti-VSVG ab overnight at
4uC. The immune complexes were pulled down using Protein A
Sepharose. After washing off the unbound material, the protein
was eluted by boiling in Endo-H buffer (0.1 m sodium citrate
[pH 5.5], 0.5% SDS, and 1% beta-mercaptoethanol) for 3–4 min.
The eluates were then divided into two tubes and one was
incubated with 40 U Endo-H overnight. The samples were then
boiled in SDS-PAGE sample buffer and resolved on an 8%
acrylamide gel, using standard procedures. The gels were then
scanned and the percentages of the Endo-H resistant form of
VSVG with respect to the total amounts of VSVG were quantified
using a FUJIFILM imager or ImageJ software.
Arachidonic-Acid-Release Assays
For the AA-release assays, HeLa or PCCL3 cells were labelled
for 18 h in growth medium with 0.1 mCi/ml [
3H]-arachidonic
acid. The [
3H]-arachidonic acid released into the medium was
quantified in triplicates, as described previously [46]; the
radioactivity released from cells is expressed as percentages of
the total incorporated radioactivity. [
3H]-arachidonic acid release
was quantified over a period of 15 min in experiments with
ionomycin stimulation, and over 3 min intervals in VSVG
transport experiments.
Visualization of PLA2 Activity with Fluorogenic Substrate
Visualization of PLA2 activity in HeLa cells was performed
using 1,2-bis-(4,4-difluoro-5,7- dimethyl-4-bora-3a, 4a-diaza-sin-
dacene-3-undecanoyl)-sn-glycero-3-phosphocholine, which is
known also as bis-BODIPY FL C11-PC. Liposomes containing
bis-BODIPY FL C11-PC were prepared according to the
manufacture instructions and incubated with VSV-infected HeLa
cells 1 h prior to the release of the 40uC block. The cells were fixed
at the end of the 40uC block or at different time intervals after the
temperature shift to 32uC; they were then immunolabelled for
VSVG and GM130 and examined under confocal microscopy.
The intensity of the fluorescent signals derived from bis-BODIPY
FL C11-PC hydrolysis was quantified in the Golgi area using the
LSM 3.2 software.
Supporting Information
Figure S1 Inhibition of PLA2 activity does not affect the
dynamics of Golgi-associated vesicles and the ARF/COP
machinery. (A–E) Control (A, C) and ONO-treated (B, D) HeLa
cells were permeabilised with streptolysin O and incubated with rat
brain cytosol containing 5 mM ONO (B, D) and the L294A aSNAP
mutant (C, D). The permeabilized cells were then fixed and prepared
for EM. L294A aSNAP induced the accumulation of vesicles near the
stacks in both control (C, arrowheads) and ONO-treated (D,
arrowheads) cells. Some stacks were greatly vesiculated (C, D, arrows).
(E) Quantification of the round profiles associated with the Golgi
stacks in samples treated as indicated in A–D. The PLA2 inhibitor
ONO did not induce an increase in the number of Golgi-associated
vesicles and did not affect the accumulation of Golgi vesicles in cells
treated with the L294A aSNAP mutant. (F–H) HeLa cells were
transfected with an Arf1-GFP construct and observed under confocal
microscopy, and Arf1-GFP was bleached within a small area of the
Golgi (outlined by boxes in G, H). The quantification of the GFP
signal (F) and the time-lapse images in the absence (G) and the
presence (H) of 5 mM ONO reveal a recovery of the fluorescent signal
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treated cells, indicating that the PLA2 inhibitor ONO did not affect
Arf1 turnover at the Golgi complex. (I–K) HeLa cells were incubated
either with 5 mM ONO for 30 min (I) or with 10 mg/ml BFA for
15 min (J); alternatively, they were first treated with 5 mMO N Of o r
30 min, and then 10 mg/ml BFA was added for an additional 15 min
(K). The cells were then fixed and stained for galactosyltransferase
(GalT) and b- C O P .A l o n e ,t h eP L A 2 inhibitor ONO did not affect b-
COP association with the Golgi complex (I) and did not prevent BFA-
induced displacement of b-COP from the Golgi membranes (compare
J and K). Interestingly, BFA treatment did not cause disassembly of
the Golgi complex in ONO-treated cells, although b-COP was
detached from the Golgi membranes (K). Scale bar: 300 nm (A, C),
350 nm (B, D), 9.8 mm( G ,H ) ,1 1mm( I – K ) .
Found at: doi:10.1371/journal.pbio.1000194.s001 (0.91 MB JPG)
Figure S2 Membrane transport in cPLA2-siRNAs-treat-
ed cells. (A–D) Control (A, C) and cPLA2a-siRNAs-treated (B, D)
HeLa cells were transfected with the VSVG-KDELR construct, and
incubated at 32uCtoallowtransportofVSVG-KDELRfromtheER
to the Golgi complex. The cells were then fixed directly (A, B) or
90 minafteranincubationat40uC (C,D), whichtrapped the VSVG-
KDELR in the ER that had been transported retrogradely from the
Golgi complex. Confocal microscopy suggests that VSVG-KDELR
was delivered effectively from the Golgi complex to the ER in both
control (C) and cPLA2a-siRNAs-treated (D) cells. (E, F) Control (E)
and cPLA2a-siRNAs-treated (F) HeLa cells were kept for 1 h at 4uC
with 50 mg/mltransferrin-Cy3,thenwashedandfixedaftera10 min
incubation at 37uC. Confocal images indicate that transferrin uptake
is not affected by the cPLA2 siRNAs.(G,H)Control(G)andcPLA2a-
siRNAs-treated (H) HeLa cells were incubated for 30 min at 4uC
with 100 mg/ml fluorescent wheat-germ agglutinin (WGA). The cells
were then washed and incubated at 37uCf o r1h ,a n df i x e da n d
labelled with an anti-TGN46 ab. In both control and cPLA2a-
siRNAs-treated cells, WGA was internalized and delivered to the
Golgi complex, indicating that the endopathway from the plasma
membrane to the endosomes, and from the endosomes to the TGN,
are not affected in the cPLA2a-siRNAs-treated cells. (I–P) Control (I,
K, M, O) and cPLA2a-siRNAs-treated HeLa cells (J, L, N, P) were
fixed and labelled with anti-mannose-6-phosphate receptor (M6PR)
(I, J), anti-EEA1 (K, L), anti-Sec31 (M, N), or anti-b-COP (O, P)
antibodies. The patterns of each of these markers were similar in the
control and cPLA2a-siRNAs-treated cells. Scale bar: 6 mm( A – D ) ,
20 mm (E, F), 60 mm (G–P).
Found at: doi:10.1371/journal.pbio.1000194.s002 (0.87 MB JPG)
Figure S3 Inhibition of PLA2 activity affects transport
through the Golgi complex. (A–F) HFs (A–D) and NRK cells
stably expressing sialyltransferase-HRP (ST-HRP) (E, F) were
infected with VSV (A–F), and kept at 40uC for 3 h to accumulate
VSVG in the ER, without (A, C, E) and with (B, D, F) 5 mM ONO
for the final 15 min of the temperature block. The cells were then
fixed directly (A, B) or incubated without (C, E) and with (D, F)
5 mM ONO at 32uC for 45 min before fixing. The fixed cells were
double labelled with anti-VSVG and anti-giantin antibodies (A–
D), or prepared for immuno-EM using nanogold and the HRP
protocol (E, F). After accumulation within the ER (A, B), VSVG
was efficiently exported to the plasma membrane in control cells
(C) and blocked in the Golgi area in ONO-treated cells (D). EM
revealed VSVG in the trans-Golgi compartment (E, arrows)
labelled with ST-HRP, while in ONO-treated cells most of the
VSVG remained within the cis portion of the stack (F, arrows),
which was negative for ST-HRP. (G–J) HFs were kept at 40uC for
3 h in ascorbate-free medium to accumulate PC-I in the ER (G,
H), and treated without and with 5 mM ONO for the last 15 min
of the temperature block (I, J). The cells were then incubated
without (I) and with (J) 5 mM ONO at 37uC for 45 min in medium
with ascorbic acid (to allow PC-I folding and exit from the ER),
fixed and double labelled with anti-PC-I and anti-giantin
antibodies. While in the control cells PC-I was efficiently exported
towards the plasma membrane within transport carriers (I,
arrows), ONO treatment induced accumulation of PC-I in the
Golgi area (J). (K, L) HFs infected with VSV were metabolically
labelled with [
35S]-methionine and then chased at 32uC in the
absence and presence of 5 mM ONO. At the indicated times, the
cells were solubilized and digested with endoglycosidase H (Endo-
H), which cleaves sugar chains built on the proteins early in the
secretory pathway (i.e., before their processing by medial Golgi
enzyme mannosidase-II, which convert sugars into endo-H
resistant forms). The cell lysates were then separated by SDS-
PAGE, and the gels scanned (K). The percentages of the Endo-H
resistant form of VSVG with respect to the total amounts of
VSVG were quantified (L) using a FUJIFILM imager. The data
indicate that VSVG processing to its Endo-H resistant form (which
occurs in the medial Golgi) was reduced when PLA2 activity was
inhibited. (M–O) HFs were infected with VSV, and kept at 40uC
for 3 h to accumulate VSVG in the ER. The cells were then
incubated in the presence of 5 mM ONO at 32uC for 45 min to
allow VSVG exit from the ER. Then the cells were fixed
immediately (M) or incubated for an additional 15 min (N) or
45 min (O) in fresh ONO-free medium to allow the recovery of
PLA2 activity. Immunofluorescent labelling of these ONO-treated
cells (M) reveals accumulation of VSVG within isolated Golgi
stacks labelled with an anti-giantin ab. Shortly after ONO wash-
out (N), partial reconnection of the Golgi stacks into a ribbon (N,
arrow) coincided with the reactivation of transport and the
appearance of VSVG at the cell surface (N, arrowheads); cells still
with disconnected Golgi stacks (N, asterisk) did not show VSVG at
the plasma membrane. Complete recovery of PLA2 activity
resulted in the reassembly of the Golgi stacks into a highly
connected structure and the exit of the cargo to the plasma
membrane (O). Scale bar: 8.2 mm (A–D, N, O), 300 nm (E, F),
9.8 mm (G–J), 4 mm (M).
Found at: doi:10.1371/journal.pbio.1000194.s003 (0.77 MB JPG)
Figure S4 The PLA2 inhibitor ONO affects Golgi-
associated tubular structures. (A–G) Control (A, C, E, F)
and ONO-treated (B, D, E, G) HFs were fixed for confocal
microscopy (A, B) or EM (C–G). (A, C) Confocal images of control
cells labelled with an anti-giantin ab and EM show that the Golgi
ribbon (A) comprises stacks connected by tubules (C). (B, D) The
ribbon is fragmented under 5 mM ONO treatment, producing
isolated islands located in a perinuclear area. (E) Morphometric
quantification of the surface area of the Golgi complex under EM
(mean6SD; n=30 stacks) shows a reduction in tubular profiles in
ONO-treated cells. (F, G) Virtual slices from EM tomograms of
control cells (see Video S6) show tubular connections between
cisternae located at different levels of the stack (F, arrowhead) and
a lack of intercisternal connections (see Video S7) in ONO-treated
cells (G). (H–J) ONO-treated cells were washed with fresh medium
for 15 min, fixed, and prepared for confocal microscopy (H) and
EM (I). Cells showed long tubules (H, arrows) that reconnect single
Golgi fragments into a ribbon. The EM tomogram (see Video S8)
corresponding to the stack shown in (I) provide a three-
dimensional model (J), with an intercisternal tubular connection
indicated (I, J, arrow). (K) Quantification of vertical connections
per stack in sections (mean6s.e.; n=10 stacks) in EM tomograms
(see Materials and Methods), in control cells, in ONO-treated
cells, and following ONO washout. Scale bar: 7 mm (A, B),
300 nm (C, D, F, G), 3.4 mm (H), 120 nm (I, J).
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Figure S5 VSVG transport in immortalized murine lung
fibroblasts from cPLA2-KO mice. Immortalized murine lung
fibroblasts from cPLA2a KO (IMLFs
2/2, A–D) and control
(IMLFs
+/+, E–H) mice were infected with VSV. The cells were
kept at 40uC for3 h to accumulate VSVG inthe ER. Pyrrophenone
(0.5 mm; Pyr; specific cPLA2a was added to the cells during the final
15 min of the temperature block (B, D, F, H). The cells were then
fixed directly (A, B, E, F) or incubated either without (C, G) or with
0.5 mm pyrrophenone (D, H) at 32uC for 60 min before fixation.
The fixed cells were double labelled with anti-VSVG and anti-
GM130 antibodies. After accumulation within the ER (A, B, E, F),
VSVG was efficiently exported first to the plasma membrane in
both untreated (C)andpyrrophenone-treated (D) IMLFs
2/2aswell
as in untreated IMLFs
+/+ (G). In contrast pyrrophenone-treated
IMLFs
+/+ (H) showed significant amounts of VSVG retained within
the Golgi complex. Bar, 7.2 mm (A–H).
Found at: doi:10.1371/journal.pbio.1000194.s005 (0.45 MB JPG)
Figure S6 Schematic illustration of how tubular ele-
ments can connect cisternae across the Golgi stack. (A)
The scheme shows a portion of a Golgi ribbon, where
neighbouring stacks are connected to each other by horizontal
membranes bridges (outlined in blue). Lack of vertical connections
between some cisternae within one stack can be compensated for
by the presence of these connections (outlined in red; 1, 2, 3) in
neighbouring stacks. These three vertical connections are sufficient
to provide membrane continuum between the cis and trans
compartments across all three of the stacks. (B) This scheme
illustrates that only a very few transient connections need to be
present in a stack at any given time to support intra-Golgi
transport. At Time Point 1, only a single vertical connection
(outlined by solid line) is present within the stack and would
provide exchange of material between the 2
nd and 3
rd cisternae.
This connection disappears (outlined by dashed line) at Time Point
2; however, the generation of new connections (outlined by solid
line) would allow further transport between the 1
st and 2
nd and 3
rd
and 4
th cisternae. Then the cycle can be repeated.
Found at: doi:10.1371/journal.pbio.1000194.s006 (0.23 MB JPG)
Video S1 Arrival of cargo protein to the Golgi complex
induces binding of the cPLA2a-C2 domain to the Golgi
membranes.
Found at: doi:10.1371/journal.pbio.1000194.s007 (3.64 MB
MOV)
Video S2 EM tomography reveals tubular bridges
between cisternae located at the different levels of the
Golgi stack in HeLa cells.
Found at: doi:10.1371/journal.pbio.1000194.s008 (3.37 MB
MOV)
Video S3 cPLA2a siRNAs affect the tubular structures
associated with the Golgi stack.
Found at: doi:10.1371/journal.pbio.1000194.s009 (2.65 MB
MOV)
Video S4 EM tomography reveals tubular bridges
between cisternae located at the different levels of the
Golgi stack in NZ-treated HeLa cells.
Found at: doi:10.1371/journal.pbio.1000194.s010 (1.06 MB
MOV)
Video S5 cPLA2a siRNAs affect the tubular structures
associated with the Golgi ministacks in NZ-treated HeLa
cells.
Found at: doi:10.1371/journal.pbio.1000194.s011 (1.55 MB
MOV)
Video S6 EM tomography reveals tubular bridges
between cisternae located at the different levels of the
Golgi stack in HFs.
Found at: doi:10.1371/journal.pbio.1000194.s012 (4.94 MB
MOV)
Video S7 PLA2 inhibition affects the tubular structures
associated with the Golgi stack.
Found at: doi:10.1371/journal.pbio.1000194.s013 (2.11 MB
MOV)
Video S8 Recovery of PLA2 activity induces reassembly
of tubular bridges between cisternae located at the
different levels of the Golgi stack.
Found at: doi:10.1371/journal.pbio.1000194.s014 (2.26 MB
MOV)
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